Company Data
Calliditas Therapeutics AB
Ticker
CALT
Current Price
$40.0001
Market Cap
$1.1B
Price Target
Refer to Report
Volume
710
52wk Range
$16 - $43
Overview
Calliditas Therapeutics AB is a biopharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.